Boston, MA – Sai Life Sciences, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), recently convened its highly…
Read More
Canadian Researchers Identify HIV Drug Maraviroc as Potential Treatment for Glioblastoma by Disrupting Brain Cell Communication
In a landmark discovery published in the journal Neuron, a collaborative team of scientists from McMaster University and The Hospital…
Read More
Sidewinder Therapeutics Secures $137 Million in Series B Financing to Advance Bispecific Antibody-Drug Conjugate Pipeline
Sidewinder Therapeutics has announced the successful closure of a substantial $137 million Series B financing round, a significant development signaling…
Read More
New York Times-lauded Medvi is marketing QUAD, a four-drug ED cocktail with a Parkinson’s drug component
The digital health company MEDVi, recently spotlighted in an April 2 New York Times profile that depicted CEO Matthew Gallagher…
Read More
Snail-Inspired Soft Robots Poised to Revolutionize Precision Drug Delivery for Cancer and Beyond
Inspired by the remarkable locomotion of gastropods, a pioneering drug delivery project led by the University of Manchester has secured…
Read More
Gilead Acquires Antibody-Drug Conjugate Pioneer Tubulis for Up to $5 Billion, Bolstering Oncology Pipeline
Sixteen months after forging a strategic collaboration, Gilead Sciences has announced its definitive agreement to acquire German biotechnology firm Tubulis,…
Read More
Penn Engineering and CHOP Researchers Develop Advanced Bone Marrow on a Chip to Revolutionize Drug Development and Space Medicine
In a significant leap for bioengineering and regenerative medicine, a collaborative team from the University of Pennsylvania School of Engineering…
Read More
JAMA Study Links Moderate Caffeine Intake to Lower Dementia Risk, Providing a Potent Nudge for Adenosine Pathway Drug Hunters
A comprehensive prospective cohort study, published online February 9, 2026, in the prestigious journal JAMA, has unveiled compelling evidence suggesting…
Read More
International Researchers Uncover Crucial Protein in Malaria Parasite Life Cycle, Offering New Hope for Drug Development
Researchers from a consortium of international institutions have made a significant breakthrough in understanding the complex life cycle of the…
Read More
Evogene, Systasy and LMU University Hospital Munich team up on AI-driven drug discovery for inflammatory diseases
An ambitious new international collaboration, bolstered by a prestigious pan-European EUREKA grant, is set to revolutionize the treatment landscape for…
Read More
